|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Personal history of in-situ neoplasm
ICD-10 (CM) Code and Descriptor
|
Z86.000 |
Personal history of in-situ neoplasm of breast
This code is considered unacceptable as a principal diagnosis.
|
Z86000 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 8.67%
|
26.66%
|
17.10%
|
12.68%
|
8.85%
|
6.31%
|
4.81%
|
3.21%
|
2.45%
|
1.97%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z86.000*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,712
|
1,713
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
1,031
|
1,031
|
|
77066
|
DX MAMMO INCL CAD BI |
924
|
924
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
398
|
398
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
377
|
380
|
|
80053
|
COMPREHEN METABOLIC PANEL |
353
|
353
|
|
77065
|
DX MAMMO INCL CAD UNI |
289
|
289
|
|
C8908
|
MRI W/O FOL W/CONT, BREAST, |
190
|
190
|
|
76641
|
ULTRASOUND BREAST COMPLETE |
162
|
162
|
|
76642
|
ULTRASOUND BREAST LIMITED |
154
|
155
|
|
77067
|
SCR MAMMO BI INCL CAD |
151
|
151
|
|
77063
|
BREAST TOMOSYNTHESIS BI |
141
|
141
|
|
A9585
|
GADOBUTROL INJECTION |
82
|
5,327
|
|
82565
|
ASSAY OF CREATININE |
71
|
71
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
66
|
9,289
|
|
C8937
|
CAD BREAST MRI |
60
|
62
|
|
82306
|
VITAMIN D 25 HYDROXY |
54
|
54
|
|
G1004
|
CDSM NDSC |
53
|
67
|
|
82728
|
ASSAY OF FERRITIN |
48
|
48
|
|
80061
|
LIPID PANEL |
42
|
42
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z86.000 related to the following DRG Codes:
951
|
